Address: C76, Balewadi, Pune, Maharashtra

Global Viscosupplementation Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Viscosupplementation Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Viscosupplementation Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Viscosupplementation Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 16 Apr 2021
  • Report ID: HLT 00183
  • Pages:197
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

Global Viscosupplementation Market is anticipated to rise at a value CAGR of 8.7% over 2019-2028. According to a study published by Insure Insights on the Global Viscosupplementation Market. Viscosupplementation is a medical technique; here, a gel-like fluid called hyaluronic acid is injected into the knee joint. Hyaluronic acid is a naturally-occurring lubricant that helps in smoother joint movement. It is primarily being used in the treatment of Knee Osteoporosis. It is the most preferred treatment for Osteoporosis when Knee replacement is not preferred. The rise in the R&D activities in viscosupplementation has driven the market growth.

Top Driver: The rise in the incidences of Osteoporosis around the globe have escalated the demand of the market

The increase in the prevalence of Osteoporosis around the globe and the rise in the geriatric population have primarily driven the market growth. Favorable reimbursement scenarios regarding the use of viscosupplements and an increase in the demand for non-surgical treatments for osteoarthritis has positively influenced the market growth. The advancements in the improvement of hyaluronic acid-based therapies. Viscosupplements are found to be a promising treatment to prevent the effects of Viscosupplements and are regarded as the most effective treatment for knee osteoarthritis.

Three injection have made the highest segmental growth in the Global Viscosupplementation Market

Based on the Product, Three injection segment have held the highest segmental growth as it is widely preferred by the physicians, high commercialized three injections have further propelled the segmental growth. Single injection products are expected to grow at a faster rate in the forecast period as they have, and fewer adverse effects and associated pain requires reduced hospital visits, and have comparatively a shorter regimen.

In terms of the Application, Knee, Osteoporosis segment have gained remarkable growth owing to the high incidence of Knee Osteoporosis, Viscosupplementation is preferred treatment I Knee Osteoporosis if knee replacement is not desired. In terms of the End User, Hospitals segment have held the most remarkable growth owing to the availability of better healthcare facilities, and availability of skilled physicians in hospitals

Asia Pacific boosts the regional market due to an increase in the Healthcare Facilities in the region   

The technologically advanced healthcare facilities in countries like China, Japan, India, etc. in the region are primarily driving regional growth. Asia Pacific has witnessed a surge in population growth, and the rise in the elderly population has escalated regional growth. The increase in healthcare spending and governmental initiatives for better health of the individuals have boosted the demand for the market. The rise in the demand for non-surgical techniques has further escalated the market.

Product Launches, Technological innovations, Strategic Collaborations, Mergers, and Acquisition, are the major strategies of the competitors

The Players of the Global Viscosupplementation Market is highly fragmented.  Product Launches, Technological innovations, Collaborations, Mergers, and acquisitions are strategies used by competitors. The key competitors of the Global Viscosupplementation Market Bioventus, Ferring B.V., Lifecore Biomedical, LLC, Sanofi, Anika Therapeutics, Inc., F. Hoffmann-La Roche Ltd, Fidia Farmaceutici s.p.a., Bausch Health, Smith & Nephew, and Alcon Vision LLC

Bioventus:  Bioventus, is one of the key competitors of the Global Viscosupplementation Market; for instance, In March 2018, Bioventus had announced the launch of DUROLANE, it is a single-injection, hyaluronic acid product used for joint lubrication in the treatment of pain associated with knee osteoarthritis. DUROLANE also consists of three-injection HA GELSYN-3 and the five-injection HA SUPARTZ FX.

Sanofi: Sanofi is a popular competitor in the Global Viscosupplementation Market. In January 2020, Sanofi had announced the acquisition of Synthorx, Inc. The acquisition was made by Sanofi to strengthen its R&D and to enhance its position to be a leader in the area of oncology and immunology.

Hoffmann-La Roche Ltd: In the year 2019 Roche had announced the acquisition of Spark Therapeutics, for USD 4.3 billion. This agreement was made by Roche to expand its product portfolio.

Scope of the Report

By Product Type

  • Single Injection
  • Three Injection
  • Five Injection

By Application

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis

By End User

  • Hospitals
  • Orthopedic Clinic
  • Ambulatory Surgical Center

By Region

  • North America
  • Europe
  • Asia Pacific

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Viscosupplementation Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Viscosupplementation Market -Industry Snapshots

6.1             Overview

6.1.1          Global Viscosupplementation Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Viscosupplementation Market Analysis, by Product Type

7.1             Overview

7.2             Key Findings for Viscosupplementation Market- By Product Type

7.2.1          Viscosupplementation Market- Single Injection

7.2.2          Viscosupplementation Market- Three Injection

7.2.3          Viscosupplementation Market- Five Injection

Chapter 8           Global Viscosupplementation Market Analysis, by Application

8.1             Overview

8.2             Key Findings for Viscosupplementation Market- By Application

8.2.1          Viscosupplementation Market- Knee Osteoarthritis

8.2.2          Viscosupplementation Market- Hip Osteoarthritis

8.2.3          Viscosupplementation Market- Hand Osteoarthritis

Chapter 9           Global Viscosupplementation Market Analysis, by End User

9.1             Overview

9.2             Key Findings for Viscosupplementation Market- By End User

9.2.1          Viscosupplementation Market- Hospitals

9.2.2          Viscosupplementation Market- Orthopedic Clinic

9.2.3          Viscosupplementation Market- Ambulatory Surgical Center

Chapter 10       Viscosupplementation Market Analysis by Region

10.1           Key Findings for Viscosupplementation Market- By region

10.2           Overview

10.2.1       Global Viscosupplementation Market Analysis, By Product Type, 2019 – 2028

10.2.2       Global Viscosupplementation Market Analysis, By Application, 2019 – 2028

10.2.3       Global Viscosupplementation Market Analysis, By End User, 2019 – 2028

10.3           Viscosupplementation Market – North America

10.3.1       Overview

10.3.2       U.S.

10.3.3       Canada

10.3.4       Mexico

10.3.5       North America Market, By Product Type

10.3.6       North America Market, By Application

10.3.7       North America Market, By End User

10.4           Viscosupplementation Market – Europe

10.4.1       Overview

10.4.2       Germany

10.4.3       United Kingdom

10.4.4       France

10.4.5       Italy

10.4.6       Rest Of Europe

10.4.7       Europe Market, By Product Type

10.4.8       Europe Market, By Application

10.4.9       Europe market by, End User

10.5           Viscosupplementation Market – Asia Pacific

10.5.1       Overview

10.5.2       China

10.5.3       Japan

10.5.4       India

10.5.5       Rest of APAC

10.5.6       Asia Pacific Market, By Product Type

10.5.7       Asia Pacific Market, By Application

10.5.8       Asia Pacific Market, By End User

10.6           Viscosupplementation Market – LAMEA

10.6.1       Overview

10.6.2       Middle East & Africa (MEA)

10.6.3       Latin America

10.6.4       Rest Of World

10.6.5       Latin America, Middle East and Africa Market, By Product Type

10.6.6       Latin America, Middle East and Africa Market, By Application

10.6.7       Latin America, Middle East and Africa Market, By End User

Chapter 11       Market Competition Analysis

11.1           Market Share/Positioning Analysis

11.1.1       Market Positioning of Key Vendors, 2019

11.1.2       Key Strategies Adopted by the Leading Players

11.1.3       Recent Developments

Chapter 12       Company Profiles- Snapshot

12.1           Bioventus

12.1.1       Business Fundamentals

12.1.2       Financial Snapshots

12.1.3       Product Portfolio

12.1.4       Recent Developments

12.2           Ferring B.V.

12.3           Lifecore Biomedical, LLC

12.4           Sanofi

12.5           Anika Therapeutics, Inc

12.6           F. Hoffmann-La Roche Ltd

12.7           Fidia Farmaceutici s.p.a

12.8           Bausch Health

12.9           Smith & Nephew

12.10        Alcon Vision LLC

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 13       Appendix




Request for Sample

Please fill out the form to receive sample pages of the report